Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients. [electronic resource]
Producer: 20100917Description: 2003-10 p. digitalISSN:- 1473-4877
- Administration, Oral
- Adult
- Aged
- Boronic Acids -- administration & dosage
- Cross-Over Studies
- Diabetes Mellitus, Type 2 -- drug therapy
- Dipeptidyl Peptidase 4
- Dipeptidyl-Peptidase IV Inhibitors -- administration & dosage
- Drug Interactions
- Drug Therapy, Combination
- Female
- Humans
- Hypoglycemic Agents -- administration & dosage
- Male
- Metformin -- administration & dosage
- Middle Aged
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.